MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Staging and clinical correlates of cortical thinning in Parkinson’s disease

H. Wilson, F. Niccolini, C. Pellicano, P. Piccini, M. Politis (London, United Kingdom)

Meeting: 2016 International Congress

Abstract Number: 719

Keywords: Cognitive dysfunction, Magnetic resonance imaging(MRI), Motor control, Motor cortex

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Pathophysiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: By using a novel disease staging model to investigate the progression and clinical associations of cortical thinning in Parkinson’s disease (PD) patients.

Background: The pathological progression of PD develops to affect cerebral cortical regions and previous studies have reported cortical thinning in PD. However, the relationship between cortical thinning with disease progression and clinical correlates remains unclear.

Methods: We analysed T1-weighted MRI images from 80 age-matched non-demented PD patients using FreeSurfer image analysis suite. We used a novel Disease Burden Score (DBS), which incorporated disease duration and motor dysfunction scores [Hoehn and Yahr (H&Y) OFF and Unified Parkinson’s disease Rating Scale (UPDRS)-III OFF], and we divided Parkinson’s patients into 3 groups: (1) early PD (n=27) low DBS: <200 (reflecting H&Y 1-2, average UPDRS-III of 21, average disease duration 3 years); (2) moderate PD (n=27) medium DBS: 221-900 (reflecting H&Y 2-3, average UPDRS-III of 32, average disease duration 7 years); and (3) advanced PD (n=26) high DBS: >901 (reflecting H&Y 3-4, average UPDRS-III of 49, average disease duration 13 years). We compared whole-brain surfaced-based cortical thickness measures and deep grey matter nuclei volumes between the 3 groups and assessed for associations with clinical measures including Mini Mental State Examination (MMSE).

Results: PD patients in the advanced group showed significant cortical thinning in the superior and inferior parietal, precuneus, superior and inferior temporal gyrus, lingual gyrus, pericalcarine, cuneus, lateral occipital cortex, precentral, postcentral and paracentral cortex; and significant loss of subcortical nuclei volume in the thalamus and caudate compared to the early stage PD group. Increasing DBS was significantly associated with degeneration in the parietal (superior and inferior parietal cortex), temporal (superior and inferior temporal gyrus, precuneus cortex), occipital (lingual gyrus, pericalcarine, cuneus, lateral occipital cortex), central motor regions (postcentral and paracentral), thalamus and caudate. Furthermore, decline in MMSE scores correlated with cortical thinning in the superior temporal gyrus, inferior parietal cortex and precuneus cortex.

Conclusions: Our findings demonstrate that as PD advances patients exhibit cortical thinning that correlates with increased motor dysfunction and could contribute to cognitive dysfunction.

To cite this abstract in AMA style:

H. Wilson, F. Niccolini, C. Pellicano, P. Piccini, M. Politis. Staging and clinical correlates of cortical thinning in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/staging-and-clinical-correlates-of-cortical-thinning-in-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/staging-and-clinical-correlates-of-cortical-thinning-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley